These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34043900)

  • 21. Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience.
    Mostafavi M; Gaitanis J
    Semin Pediatr Neurol; 2020 Oct; 35():100833. PubMed ID: 32892960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review.
    Roy A; Roy M; Deb S; Unwin G; Roy A
    J Intellect Disabil Res; 2015 Apr; 59(4):293-306. PubMed ID: 24589346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder: A Systematic Review, Meta-analysis, and Meta-regression.
    Oliver LD; Moxon-Emre I; Lai MC; Grennan L; Voineskos AN; Ameis SH
    JAMA Psychiatry; 2021 Mar; 78(3):281-292. PubMed ID: 33291141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review.
    Ibsen EWD; Thomsen PH
    Nord J Psychiatry; 2024 Jul; ():1-8. PubMed ID: 39037073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis.
    D'Alò GL; De Crescenzo F; Amato L; Cruciani F; Davoli M; Fulceri F; Minozzi S; Mitrova Z; Morgano GP; Nardocci F; Saulle R; Schünemann HJ; Scattoni ML;
    Health Qual Life Outcomes; 2021 Jan; 19(1):33. PubMed ID: 33494757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment.
    Quillet JC; Siani-Rose M; McKee R; Goldstein B; Taylor M; Kurek I
    Sci Rep; 2023 Aug; 13(1):13022. PubMed ID: 37608004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis.
    Gedin F; Blomé S; Pontén M; Lalouni M; Fust J; Raquette A; Vadenmark Lundquist V; Thompson WH; Jensen K
    JAMA Netw Open; 2022 Nov; 5(11):e2243848. PubMed ID: 36441553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder.
    Thom RP; Pereira JA; Sipsock D; McDougle CJ
    Curr Psychiatry Rep; 2021 Oct; 23(12):79. PubMed ID: 34643815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach.
    Gharbi KA; Bonomo YA; Hallinan CM
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review.
    Fletcher S; Pawliuk C; Ip A; Huh L; Rassekh SR; Oberlander TF; Siden H
    Child Care Health Dev; 2022 Jan; 48(1):33-44. PubMed ID: 34403168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
    Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study.
    Aran A; Cassuto H; Lubotzky A; Wattad N; Hazan E
    J Autism Dev Disord; 2019 Mar; 49(3):1284-1288. PubMed ID: 30382443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repetitive Transcranial Magnetic Stimulation for Treatment of Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
    Barahona-Corrêa JB; Velosa A; Chainho A; Lopes R; Oliveira-Maia AJ
    Front Integr Neurosci; 2018; 12():27. PubMed ID: 30038561
    [No Abstract]   [Full Text] [Related]  

  • 36. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report.
    Ponton JA; Smyth K; Soumbasis E; Llanos SA; Lewis M; Meerholz WA; Tanguay RL
    J Med Case Rep; 2020 Sep; 14(1):162. PubMed ID: 32958062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol.
    Fletcher S; Pawliuk C; Ip A; Oberlander T; Siden H
    JBI Evid Synth; 2021 May; 19(5):1251-1258. PubMed ID: 33165173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight status in individuals with autism spectrum disorder: A study protocol for systematic review and meta-analysis.
    Xie XN; Li YJ; Lei X; Li YM
    Medicine (Baltimore); 2019 Sep; 98(38):e17274. PubMed ID: 31568007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.
    Siani-Rose M; McKee R; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
    Cannabis Cannabinoid Res; 2023 Aug; 8(4):642-656. PubMed ID: 35343818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.